Tykerb Approved for Advanced Breast Cancer
(HealthDay)
HealthDay - TUESDAY, March 13 (HealthDay News) -- GlaxoSmithKline's Tykerb
(lapatinib) has been approved by the U.S. Food and Drug Administration to
treat advanced breast cancer when other cancer drugs haven't succeeded,
the agency said Tuesday.
Read more...
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace